NASDAQ : ACHC
Acadia Healthcare Company, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 29.96 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.79B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.79B |
| Enterprise Value | 5.21B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 93.10M |
| Shares Outstanding | 93.10M |
| Shares Change (YoY) | -1.29% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 1.66% |
| Owned by Institutions (%) | 145.22% |
| Float | 91.53M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 17.71 |
| PS Ratio | 0.83 |
| Forward PS | 0.79 |
| PB Ratio | 1.38 |
| P/TBV Ratio | 4.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 13.25 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.55 |
| EV / EBITDA | 9.73 |
| EV / EBIT | 15.37 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.57 |
| Quick Ratio | 1.35 |
| Debt / Equity | 1.18 |
| Debt / EBITDA | 4.44 |
| Debt / FCF | n/a |
| Interest Coverage | 2.24 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -41.44% |
| Return on Assets (ROA) | 3.57% |
| Return on Invested Capital (ROIC) | 7.28% |
| Return on Capital Employed (ROCE) | 6.76% |
| Weighted Average Cost of Capital (WACC) | 6.21% |
| Revenue Per Employee | $134,707 |
| Profits Per Employee | -$45,050 |
| Employee Count | 25,000 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 328.64 |
Taxes
| Measure | Value |
|---|
| Income Tax | 25.76M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +30.20% |
| 50-Day Moving Average | 29.08 |
| 200-Day Moving Average | 25.79 |
| Relative Strength Index (RSI) | 50.48 |
| Average Volume (20 Days) | 1,672,777 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 20.94M |
| Short Previous Month | 22.77M |
| Short % of Shares Out | 22.49% |
| Short % of Float | 22.88% |
| Short Ratio (days to cover) | 13.19 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.37B |
| Gross Profit | 1.38B |
| Operating Income | 338.77M |
| Pretax Income | -1.10B |
| Net Income | -1.13B |
| EBITDA | 534.85M |
| EBIT | 338.77M |
| Loss Per Share | -$12.44 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 171.29M |
| Total Debt | 2.59B |
| Net Cash | -2.42B |
| Net Cash Per Share | -$25.95 |
| Equity (Book Value) | 2.19B |
| Book Value Per Share | 21.78 |
| Working Capital | 307.71M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 210.52M |
| Capital Expenditures | -344.55M |
| Depreciation & Amortization | 196.08M |
| Net Borrowing | 143.69M |
| Free Cash Flow | -134.03M |
| FCF Per Share | -$1.44 |
Margins
| Measure | Value |
|---|
| Gross Margin | 41.06% |
| Operating Margin | 10.06% |
| Pretax Margin | -32.56% |
| Profit Margin | -33.44% |
| EBITDA Margin | 15.88% |
| EBIT Margin | 10.06% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.29% |
| Shareholder Yield | 1.29% |
| Earnings Yield | -41.53% |
| FCF Yield | -4.81% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $33.79 |
| Price Target Difference | 12.78% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 4.82% |
| EPS Growth Forecast (3Y) | 2.82% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.04 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |